Stocks Screener

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Alpha Teknova Inc

TKNO
Current price
6.56 USD +0.26 USD (+4.13%)
Last closed 6.25 USD
ISIN US02080L1026
Sector Healthcare
Industry Drug Manufacturers - Specialty & Generic
Exchange NASDAQ
Capitalization 381 649 472 USD
Yield for 12 month +206.54 %
1Y
3Y
5Y
10Y
15Y
TKNO
21.11.2021 - 28.11.2021

Alpha Teknova, Inc. produces critical reagents for the research, discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics in the United States and internationally. The company offers pre-poured media plates for cell growth and cloning; liquid cell culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification. It provides lab essentials which provides chemical formulations for use in biological research and drug discovery; and clinical solutions, a custom product used in the development and production of protein therapies, gene therapies, mRNA vaccines, and diagnostic kits. The company serves its products to life sciences market, including pharmaceutical and biotechnology companies, contract development and manufacturing organizations, in vitro diagnostic franchises, as well as academic and government research institutions. Alpha Teknova, Inc. was founded in 1996 and is headquartered in Hollister, California. Address: 2451 Bert Dr., Hollister, CA, United States, 95023

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

8 USD

P/E ratio

Dividend Yield

Current Year

+36 684 000 USD

Last Year

+41 420 000 USD

Current Quarter

+9 576 000 USD

Last Quarter

+9 614 000 USD

Current Year

+9 148 000 USD

Last Year

+17 476 000 USD

Current Quarter

+377 000 USD

Last Quarter

+2 804 000 USD

Key Figures TKNO

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -23 442 000 USD
Operating Margin TTM -53.05 %
PE Ratio
Return On Assets TTM -15.1 %
PEG Ratio
Return On Equity TTM -41.51 %
Wall Street Target Price 8 USD
Revenue TTM 34 940 000 USD
Book Value 2.21 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY -16.6 %
Dividend Yield
Gross Profit TTM 17 476 000 USD
Earnings per share -0.92 USD
Diluted Eps TTM -0.92 USD
Most Recent Quarter III 2024
Quarterly Earnings Growth YOY
Profit Margin -98.08 %

Dividend Analytics TKNO

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History TKNO

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor
Payout Ratio
Last Split Date
Dividend Date

Stock Valuation TKNO

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue 10.8654
Price Sales TTM 10.5111
Enterprise Value EBITDA -6.2315
Price Book MRQ 4.6531

Financials TKNO

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators TKNO

For 52 weeks

1.16 USD 7.92 USD
50 Day MA 5.53 USD
Shares Short Prior Month 283 697
200 Day MA 3.34 USD
Short Ratio 2.03
Shares Short 320 560
Short Percent 1.5 %